Inhibikase Therapeutics Inc. (IKT)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1. 6,325,000 $20,556,250 1.29%
2.
Perceptive Advisors

Joseph Edelman

5,925,000 $19,256,250 0.53%
3.
Commodore Capital

Egen Atkinson And Michael Kramarz

5,925,000 $19,256,250 1.41%
4.
ADAR1 Capital Management

Daniel Schneeberger

5,103,005 $16,584,766 3.31%
5.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

2,190,000 $7,117,500 0.3%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.37 1,460,000 1,460,000 2024-10-21 Filing
$1.37 145,000 145,000 2024-10-21 Filing
$1.37 365,000 365,000 2024-10-21 Filing
$0.80 5,000 Large Shareholder, Officer, Director 5,335,433 2022-08-16 Filing
$0.98 5,000 Large Shareholder, Officer, Director 5,330,433 2022-05-27 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 10,950,000 $35,587,500 7.74%
2. 6,125,000 $19,906,250 1.97%
3. 2,838,645 $9,225,596 0%
4. 2,070,684 $6,729,723 0.03%
5. 335,460 $1,090,245 0%
News See All